Parnax Lab Limited (BOM:506128)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 25, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,436	1,229	1,488	598	1,120	166
Market Cap Growth	-17.39%	-17.39%	148.81%	-46.60%	575.13%	60.89%
Enterprise Value	2,106	1,966	2,057	1,171	1,740	638
Last Close Price	125.00	107.00	129.53	52.06	131.65	19.50
PE Ratio	12.44	10.67	15.48	6.94	13.58	-
PS Ratio	0.76	0.66	0.79	0.36	0.69	0.18
PB Ratio	1.72	1.48	2.08	0.96	2.32	0.51
P/TBV Ratio	1.92	1.64	2.10	0.97	2.33	0.51
P/FCF Ratio	10.46	8.96	-	6.21	-	-
P/OCF Ratio	4.44	3.81	9.37	2.86	13.10	2.63
EV/Sales Ratio	1.12	1.05	1.09	0.70	1.07	0.71
EV/EBITDA Ratio	7.87	7.35	9.03	5.20	7.64	6.43
EV/EBIT Ratio	10.86	10.14	12.26	7.02	10.09	12.89
EV/FCF Ratio	15.34	14.33	-	12.16	-	-
Debt / Equity Ratio	0.84	0.84	1.13	0.88	1.43	1.81
Debt / EBITDA Ratio	2.60	2.60	3.41	2.36	3.00	5.86
Debt / FCF Ratio	5.07	5.07	-	5.68	-	-
Asset Turnover	0.99	0.99	1.13	1.12	1.25	0.85
Inventory Turnover	3.45	3.45	4.13	4.49	6.11	4.08
Quick Ratio	0.45	0.45	0.42	0.47	0.54	0.36
Current Ratio	0.92	0.92	0.92	0.97	0.92	0.72
Return on Equity (ROE)	14.89%	14.89%	14.37%	15.62%	20.42%	-1.11%
Return on Assets (ROA)	6.40%	6.40%	6.28%	6.98%	8.30%	2.90%
Return on Capital (ROIC)	7.94%	7.94%	7.79%	8.89%	10.32%	3.52%
Return on Capital Employed (ROCE)	16.80%	16.80%	15.70%	20.30%	23.80%	9.50%
Earnings Yield	8.02%	9.37%	6.46%	14.41%	7.36%	-2.20%
FCF Yield	9.56%	11.17%	-11.12%	16.11%	-8.29%	-1.39%
Buyback Yield / Dilution	0.21%	0.21%	-3.76%	-30.04%	-0.08%	0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.